99 related articles for article (PubMed ID: 15548232)
1. Functional interaction of intestinal CYP3A4 and P-glycoprotein.
Kivistö KT; Niemi M; Fromm MF
Fundam Clin Pharmacol; 2004 Dec; 18(6):621-6. PubMed ID: 15548232
[TBL] [Abstract][Full Text] [Related]
2. Predicting Drug Extraction in the Human Gut Wall: Assessing Contributions from Drug Metabolizing Enzymes and Transporter Proteins using Preclinical Models.
Peters SA; Jones CR; Ungell AL; Hatley OJ
Clin Pharmacokinet; 2016 Jun; 55(6):673-96. PubMed ID: 26895020
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, molecular modeling, in vitro and in vivo biological evaluation of potent anthranilamide derivatives as dual P-glycoprotein and CYP3A4 inhibitors.
Said AM; Mansour YE; Soliman RR; Islam R; Fatahala SS
Eur J Med Chem; 2024 May; 273():116492. PubMed ID: 38762918
[TBL] [Abstract][Full Text] [Related]
4. Loss of orally administered drugs in GI tract.
Gavhane YN; Yadav AV
Saudi Pharm J; 2012 Oct; 20(4):331-44. PubMed ID: 23960808
[TBL] [Abstract][Full Text] [Related]
5. Predicting drug-drug interactions involving the inhibition of intestinal CYP3A4 and P-glycoprotein.
Tachibana T; Kato M; Takano J; Sugiyama Y
Curr Drug Metab; 2010 Nov; 11(9):762-77. PubMed ID: 21189139
[TBL] [Abstract][Full Text] [Related]
6. Gut-on-a-chip models for dissecting the gut microbiology and physiology.
Valiei A; Aminian-Dehkordi J; Mofrad MRK
APL Bioeng; 2023 Mar; 7(1):011502. PubMed ID: 36875738
[TBL] [Abstract][Full Text] [Related]
7. Intracellular Metabolomics Identifies Efflux Transporter Inhibitors in a Routine Caco-2 Cell Permeability Assay-Biological Implications.
Naseem A; Pal A; Gowan S; Asad Y; Donovan A; Temesszentandrási-Ambrus C; Kis E; Gaborik Z; Bhalay G; Raynaud F
Cells; 2022 Oct; 11(20):. PubMed ID: 36291153
[TBL] [Abstract][Full Text] [Related]
8. Ketoconazole Reverses Imatinib Resistance in Human Chronic Myelogenous Leukemia K562 Cells.
Prado-Carrillo O; Arenas-Ramírez A; Llaguno-Munive M; Jurado R; Pérez-Rojas J; Cervera-Ceballos E; Garcia-Lopez P
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887063
[TBL] [Abstract][Full Text] [Related]
9. Solid Lipid Nanoparticles for Efficient Oral Delivery of Tyrosine Kinase Inhibitors: A Nano Targeted Cancer Drug Delivery.
Satapathy S; Patro CS
Adv Pharm Bull; 2022 Mar; 12(2):298-308. PubMed ID: 35620346
[TBL] [Abstract][Full Text] [Related]
10. Transport of Drugs and Endogenous Compounds Mediated by Human OCT1: Studies in Single- and Double-Transfected Cell Models.
Haberkorn B; Fromm MF; König J
Front Pharmacol; 2021; 12():662535. PubMed ID: 33967805
[TBL] [Abstract][Full Text] [Related]
11. The inhibitory effects of mitragynine on P-glycoprotein in vitro.
Rusli N; Amanah A; Kaur G; Adenan MI; Sulaiman SF; Wahab HA; Tan ML
Naunyn Schmiedebergs Arch Pharmacol; 2019 Apr; 392(4):481-496. PubMed ID: 30604191
[TBL] [Abstract][Full Text] [Related]
12. Effects of Gingko biloba extract on tissue distribution of fluoxetine and venlafaxine in rats.
Hussain SA; Alzubaidi FA; Hashem HO
J Intercult Ethnopharmacol; 2015; 4(3):234-8. PubMed ID: 26401414
[TBL] [Abstract][Full Text] [Related]
13. Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp.
Alfarouk KO; Stock CM; Taylor S; Walsh M; Muddathir AK; Verduzco D; Bashir AH; Mohammed OY; Elhassan GO; Harguindey S; Reshkin SJ; Ibrahim ME; Rauch C
Cancer Cell Int; 2015; 15():71. PubMed ID: 26180516
[TBL] [Abstract][Full Text] [Related]
14. Transporter-mediated drug-drug interactions with oral antidiabetic drugs.
Klatt S; Fromm MF; König J
Pharmaceutics; 2011 Oct; 3(4):680-705. PubMed ID: 24309303
[TBL] [Abstract][Full Text] [Related]
15. Rhabdomyolysis secondary to drug interaction between atorvastatin, omeprazole, and dexamethasone.
Elazzazy S; Eziada SS; Zaidan M
Int Med Case Rep J; 2012; 5():59-61. PubMed ID: 23754925
[TBL] [Abstract][Full Text] [Related]
16. Incorporation of ABCB1-mediated transport into a physiologically-based pharmacokinetic model of docetaxel in mice.
Hudachek SF; Gustafson DL
J Pharmacokinet Pharmacodyn; 2013 Aug; 40(4):437-49. PubMed ID: 23616082
[TBL] [Abstract][Full Text] [Related]
17. Cytochrome P450-mediated changes in oxycodone pharmacokinetics/pharmacodynamics and their clinical implications.
Söderberg Löfdal KC; Andersson ML; Gustafsson LL
Drugs; 2013 May; 73(6):533-43. PubMed ID: 23605691
[TBL] [Abstract][Full Text] [Related]
18. Drug interactions: a primer for the gastroenterologist.
Doligalski CT; Tong Logan A; Silverman A
Gastroenterol Hepatol (N Y); 2012 Jun; 8(6):376-83. PubMed ID: 22933873
[TBL] [Abstract][Full Text] [Related]
19. Impact of the herbal medicine Sophora flavescens on the oral pharmacokinetics of indinavir in rats: the involvement of CYP3A and P-glycoprotein.
Yang JM; Ip SP; Xian Y; Zhao M; Lin ZX; Yeung JH; Chan RC; Lee SS; Che CT
PLoS One; 2012; 7(2):e31312. PubMed ID: 22359586
[TBL] [Abstract][Full Text] [Related]
20. The grapefruit: an old wine in a new glass? Metabolic and cardiovascular perspectives.
Owira PM; Ojewole JA
Cardiovasc J Afr; 2010; 21(5):280-5. PubMed ID: 20972517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
